UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Before investing in cryptocurrency, it's important to be informed. Discover key insights that every investor should know.
18,573 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
HPE reports a landmark shift in its earnings mix, with networking revenue over half of profits amid the Juniper Netwo...
In March 2026, investors weigh IMAX, SHARKNINJA, and SONOS as each pushes growth through screens, margins, and softwa...
As Sonida shares insights from the Q4 2025 earnings call, investors gain a clearer view of the company’s path through...
A bold bet on a geothermal energy company highlights a broader shift in the renewable energy stock year. Learn what i...
Rising oil prices amid escalating tensions weigh on the Dow and broader U.S. markets. This guide breaks down why ener...
As voice interfaces become a staple in shopping, SoundHound AI could rise as a key AI infrastructure layer. This arti...
Southern Company is near Dividend Aristocrat territory after two decades of increases, yet a massive five-year capita...
Alphabet's enormous $346 investment portfolio is quietly powering profits beyond AI hype. This article explains where...
Markets showed modest gains as the Fed meeting kicked off, with tech and travel shares helping lift indexes. This gui...
Alliant Energy Corp Stock is riding a bullish wave as three key drivers align: rising Midwest data-center demand, a d...
The federal debt surpassed $39 trillion this week, marking a watershed moment for Americans’ finances and national st...